SLC30A9 and cervical cancer: PRDM1 silencing or KO led to a marked decrease in both SLC30A9 mRNA and protein expression levels (Fig. 7A, B) in pCCa-1 primary cervical cancer cells, accompanied by a significant reduction in the luciferase activity of the SLC30A9’s promoter (Fig. 7C).